BUSINESS
India's services sector saw strong growth in April, boosting corporate optimism to a three-month high
The HSBC final India Services Purchasing Managers' Index, conducted by S&P Global, was 60.8 in April, a little below the previous month's 61.2, but a much faster growth compared to nearly 14 years ago.
India's economy and stock markets have outperformed China's over the last three years
Between 2004 and 2021, China’s economy outgrew India’s GDP at a ferocious pace but has lost some relative momentum since. Over the past 3 years, the Indian economy and equity markets have outperformed China, the report said.
Government Ends Onion Export Ban with Price Conditions
Earlier, the government allowed the export of 99,150 metric tonnes of onions on April 27 for the six neighboring countries, including Bangladesh, UAE, Bhutan, Bahrain, Mauritius, and Sri Lanka.
Survey Reveals Challenges Faced by Nearly 43% of Health Insurance Policyholders in Claim Processing Over Past 3 Years
This was overwhelmingly emphasized by 93 percent of the respondents from the study conducted by Localcircles. They pressed the onus on the need for the implementation of regulatory reforms. They suggested that Insurance companies should also be mandated to provide information about claims and policy cancellations on their websites every month.
RBI Reports Overwhelming Return of Rs 2,000 Banknotes: 97% Back in Circulation
In a statement issued on May 19, 2023, the RBI declared the withdrawal of Rs 2,000 banknotes from circulation. It stated, "The total value of Rs 2,000 banknotes in circulation, amounting to Rs 3.56 lakh crore as of May 19, 2023, when the decision to withdraw these notes was made, has now dwindled to Rs 8,470 crore as of February 29, 2024."
Bharat Biotech Affirms Covaxin's Exceptional Safety Profile
Amid concerns coming from some quarters on the safety of Covid vaccines, especially after AstraZeneca announced that it had identified a rare side effect of blood clotting and low platelet count associated with its Covid vaccine, Covishield, Bharat Biotech took the initiative to reassure the public. Additionally, apart from the adverse events, the rare side effect of blood clotting and low platelet count associated with Covishield, developed by Oxford University researchers and manufactured by Serum Institute in Pune, saw widespread administration with some 1.75 billion doses being administered in India.
Bharat Biotech Affirms Covaxin's Exceptional Safety Profile
Amid concerns coming from some quarters on the safety of Covid vaccines, especially after AstraZeneca announced that it had identified a rare side effect of blood clotting and low platelet count associated with its Covid vaccine, Covishield, Bharat Biotech took the initiative to reassure the public. Additionally, apart from the adverse events, the rare side effect of blood clotting and low platelet count associated with Covishield, developed by Oxford University researchers and manufactured by Serum Institute in Pune, saw widespread administration with some 1.75 billion doses being administered in India.
India's Bold Stance on Russian Oil Procurement Results in $8 Billion Import Bill Savings
With Prime Minister Narendra Modi at the helm of the country, the Indian government never seemed to give an inch regarding the latter's bilateral relationship with Russia with the imposition of sanctions on Russia by the Western countries.
Adani Ports & SEZ Attains AAA Rating Milestone, Pioneering Industry Standards
Managing Director of APSEZ, Karan Adani, said, "We appreciate the recognition of the financial prudence of APSEZ and its commitment to reduce debt, with strong asset and customer bases, which have offered exceptional profitability in the port sector on a global scale."
April Sees Record-Breaking GST Collection of Rs 2.1 Lakh Crore
After accounting for refunds, the net GST revenue for April 2024 is a staggering Rs 1.92 lakh crore, with an impressive 17.1 per cent growth compared to the corresponding period last year.
Don't Miss
Advertisement